Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Nucleus Cytoplasm |
Domain |
PF00069 Protein kinase domain |
Function |
Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation. |
Biological Process |
GO:0006611 protein export from nucleus GO:0006913 nucleocytoplasmic transport GO:0007050 cell cycle arrest GO:0032147 activation of protein kinase activity GO:0033674 positive regulation of kinase activity GO:0045786 negative regulation of cell cycle GO:0045860 positive regulation of protein kinase activity GO:0051168 nuclear export GO:0051169 nuclear transport GO:0071900 regulation of protein serine/threonine kinase activity GO:0071902 positive regulation of protein serine/threonine kinase activity |
Molecular Function |
GO:0008047 enzyme activator activity GO:0019207 kinase regulator activity GO:0019209 kinase activator activity GO:0019887 protein kinase regulator activity GO:0030295 protein kinase activator activity GO:0043539 protein serine/threonine kinase activator activity |
Cellular Component | - |
KEGG |
hsa04150 mTOR signaling pathway hsa04152 AMPK signaling pathway |
Reactome |
R-HSA-380972: Energy dependent regulation of mTOR by LKB1-AMPK R-HSA-2428924: IGF1R signaling cascade R-HSA-112399: IRS-mediated signalling R-HSA-2428928: IRS-related events triggered by IGF1R R-HSA-74751: Insulin receptor signalling cascade R-HSA-109704: PI3K Cascade R-HSA-109703: PKB-mediated events R-HSA-162582: Signal Transduction R-HSA-74752: Signaling by Insulin receptor R-HSA-2404192: Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-165159: mTOR signalling |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between STRADA and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of STRADA in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of STRADA in various data sets.
|
Points in the above scatter plot represent the mutation difference of STRADA in various data sets.
|
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of STRADA. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of STRADA. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by STRADA. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of STRADA. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of STRADA expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between STRADA and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | STRADA |
Name | STE20-related kinase adaptor alpha |
Aliases | NY-BR-96; LYK5; Stlk; STRAD; STE20-like pseudokinase; PMSE; STRAD alpha; protein kinase LYK5; serologically ...... |
Chromosomal Location | 17q23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting STRADA collected from DrugBank database. |
There is no record. |